185 related articles for article (PubMed ID: 32800643)
1. 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.
S'aulis D; Khoury EA; Zabel M; Rizzo WB
Mol Genet Metab; 2020; 131(1-2):253-258. PubMed ID: 32800643
[TBL] [Abstract][Full Text] [Related]
2. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
Rizzo WB
Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
[TBL] [Abstract][Full Text] [Related]
3. Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.
Staps P; Rizzo WB; Vaz FM; Bugiani M; Giera M; Heijs B; van Kampen AHC; Pras-Raves ML; Breur M; Groen A; Ferdinandusse S; van der Graaf M; Van Goethem G; Lammens M; Wevers RA; Willemsen MAAP
J Inherit Metab Dis; 2020 Nov; 43(6):1265-1278. PubMed ID: 32557630
[TBL] [Abstract][Full Text] [Related]
4. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
5. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
[TBL] [Abstract][Full Text] [Related]
6. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
Malheiro AR; da Silva TF; Brites P
J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
[TBL] [Abstract][Full Text] [Related]
7. Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.
Arai A; Takeichi T; Wakamoto H; Sassa T; Ito Y; Murase Y; Ogi T; Akiyama M; Kihara A
J Dermatol Sci; 2022 Sep; 107(3):114-122. PubMed ID: 35973883
[TBL] [Abstract][Full Text] [Related]
8. Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Rizzo WB; S'Aulis D; Jennings MA; Crumrine DA; Williams ML; Elias PM
Arch Dermatol Res; 2010 Aug; 302(6):443-51. PubMed ID: 20049467
[TBL] [Abstract][Full Text] [Related]
9. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.
Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB
J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980
[TBL] [Abstract][Full Text] [Related]
10. Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma.
Rizzo WB; Craft DA
J Lipid Res; 2000 Jul; 41(7):1077-81. PubMed ID: 10884288
[TBL] [Abstract][Full Text] [Related]
11. Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.
Rizzo WB; Dammann AL; Craft DA
J Clin Invest; 1988 Mar; 81(3):738-44. PubMed ID: 3343337
[TBL] [Abstract][Full Text] [Related]
12. Sjögren-Larsson syndrome.
Rizzo WB
Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
[TBL] [Abstract][Full Text] [Related]
13. Genotype and phenotype variability in Sjögren-Larsson syndrome.
Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
[TBL] [Abstract][Full Text] [Related]
14. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Rizzo WB; Craft DA
J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
[TBL] [Abstract][Full Text] [Related]
15. Ichthyosis, mental retardation, and asymptomatic spasticity. A new neurocutaneous syndrome with normal fatty alcohol:NAD+ oxidoreductase activity.
Koone MD; Rizzo WB; Elias PM; Williams ML; Lightner V; Pinnell SR
Arch Dermatol; 1990 Nov; 126(11):1485-90. PubMed ID: 2241202
[TBL] [Abstract][Full Text] [Related]
16. Sjögren-Larsson syndrome: inherited defect in the fatty alcohol cycle.
Rizzo WB; Dammann AL; Craft DA; Black SH; Tilton AH; Africk D; Chaves-Carballo E; Holmgren G; Jagell S
J Pediatr; 1989 Aug; 115(2):228-34. PubMed ID: 2666627
[TBL] [Abstract][Full Text] [Related]
17. Impaired Skin Barrier Function Due to Reduced ω-
Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
[TBL] [Abstract][Full Text] [Related]
18. Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds.
Keller MA; Watschinger K; Lange K; Golderer G; Werner-Felmayer G; Hermetter A; Wanders RJ; Werner ER
J Lipid Res; 2012 Jul; 53(7):1410-6. PubMed ID: 22508945
[TBL] [Abstract][Full Text] [Related]
19. Sjogren-Larsson syndrome associated hypermelanosis.
Xu YC; Hou JQ; Zhu WJ; Li P
J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
Cho KH; Shim SH; Kim M
Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
